Home - National Multiple Sclerosis Society

Skip to navigation Skip to content
National MS Society
Email not displaying correctly? View it in your browser.
eNews October 2010 - National MS Society
Meditation seen to improve symptoms of MS

Rigorous study in MS

The results of a controlled study of 150 people with relapsing-remitting or secondary-progressive MS published in a recent issue of the esteemed journal Neurology focused on whether a type of meditation called “mindfulness-based intervention” (MBI) could improve well-being in people with MS. Participants practicing MBI improved significantly more than the control group in most outcome measures. Why was this?

Read more

 Find us on Facebook 

YouTube MySpace Twitter



Ashley Kumlien

Ashley Kumlien runs the distance for MS


 Our Annual Progress Report

Our Annual Progress Report


Gilenya: What you should know Gilenya: What you should know

MS Learn Online presents two webcasts on Gilenya, the first oral disease-modifier approved for the treatment of MS. Join host Aaron Miller, MD, chief medical officer for the National MS Society, as he discusses the clinical trial findings on Gilenya, how the drug works and who should consider taking it. Transcripts of this two-part program are also available in PDF and MP3 podcast formats.

Watch videos


Spring and Summer Study shows MS disease activity higher in spring / summer.

In a recent U.S. study, researchers found that MS disease activity measured by MRI scans in 44 people with MS increased two to three times during the months of March to August compared with other times of the year. What
is the influence of the environment on MS?

Read more


Every dollar gets doubledEvery dollar gets doubled
Thanks to a generous gift from Mr. Richard Slifka, a longtime donor and leadership volunteer, your donation will be instantly doubled for a limited time only! Donate now and DOUBLE your gift toward a world free of MS.

Donate Now


More MS News
Oct 12: MS research takes center stage at ECTRIMS conference in Sweden

Oct 8: Phase III results of AVP-923 (formerly called Zenvia) shows it can reduce episodes of uncontrollable laughing or crying in MS

Read more about these and other recent reports

This communication is partially sponsored through the generous support of Bayer HealthCare, Biogen Idec, Novartis Pharmaceuticals Corporation, and Teva Neuroscience, Inc.

eNews Bayer HealthCare       MS Active Source         Novartis Pharmaceuticals       Teva Neuroscience  

Shop at the Society Store       Join a Walk MS Event       Join a Bike MS Event

National MS Society | View as Web page | Subscribe | Legal Notice/Privacy Policy | Email Preferences | Unsubscribe

MS stops people from moving. The National MS Society exists to make sure it doesn’t. We are a collective of passionate individuals, moving together to create a world free of MS.

Please do not reply to this email as we are unable to quickly respond to messages sent to this address. To receive information about living with MS, Bike MS or Walk MS — or to contact National MS Society staff in your area — please
visit our Web site.

Early and ongoing treatment with an FDA-approved therapy can make a difference for people with multiple sclerosis. Learn about your options by talking to your health care professional and contacting the National MS Society at http://www.nationalmssociety.org/ or 1-800-344-4867.

National Multiple Sclerosis Society | 733 Third Avenue | New York, NY | 10017

This message was sent to . To ensure that you continue to receive our emails, please add us to your address book.